Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Relevance and Insights on 1,4-Naphthoquinones as Antimicrobial and Antitumoral Molecules: A Systematic Review. | Pharmaceuticals (Basel) | 2023 | 37111253 | PubTator, text mining | PubMed |
| Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study. | Int J Mol Sci | 2023 | 37108604 | PubTator, text mining | PubMed |
| Resistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us. | Int J Mol Sci | 2023 | 37108395 | PubTator, text mining | PubMed |
| Deciphering the Prognostic and Therapeutic Significance of Cell Cycle Regulator CENPF: A Potential Biomarker of Prognosis and Immune Microenvironment for Patients with Liposarcoma. | Int J Mol Sci | 2023 | 37108172 | PubTator, text mining | PubMed |
| Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy - a prospective analysis. | Cardiooncology | 2023 | 37106424 | PubTator, text mining | PubMed |
| Current perspectives of cardio-oncology: Epidemiology, adverse effects, pre-treatment screening and prevention strategies. | Cancer Med | 2023 | 37102247 | PubTator, text mining | PubMed |
| A graph neural network-based interpretable framework reveals a novel DNA fragility-associated chromatin structural unit. | Genome Biol | 2023 | 37095580 | PubTator, text mining | PubMed |
| iGEM as a human iPS cell-based global epigenetic modulation detection assay provides throughput characterization of chemicals affecting DNA methylation. | Sci Rep | 2023 | 37095195 | PubTator, text mining | PubMed |
| Novel substituted 1,8-naphthyridines: Design, synthesis, radiolabeling, and evaluation of apoptosis and topoisomerase II inhibition. | Arch Pharm (Weinheim) | 2023 | 37080944 | PubTator, text mining | PubMed |
| Revisiting TOP2B-related phenotypes: Three new cases and literature review. | Clin Genet | 2023 | 37068767 | PubTator, text mining | PubMed |
| The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis. | Theranostics | 2023 | 37064875 | PubTator, text mining | PubMed |
| Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients. | Int J Biol Sci | 2023 | 37063416 | PubTator, text mining | PubMed |
| Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma. | Sci Rep | 2023 | 37061606 | PubTator, text mining | PubMed |
| Women's contribution in understanding how topoisomerases, supercoiling, and transcription control genome organization. | Front Mol Biosci | 2023 | 37051322 | PubTator, text mining | PubMed |
| Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling. | Int J Mol Sci | 2023 | 37047696 | PubTator, text mining | PubMed |
| Genome-Wide CRISPR Screens Reveal ZATT as a Synthetic Lethal Target of TOP2-Poison Etoposide That Can Act in a TDP2-Independent Pathway. | Int J Mol Sci | 2023 | 37047518 | PubTator, text mining | PubMed |
| Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer. | Oncologist | 2023 | 37027449 | PubTator, text mining | PubMed |
| 13-Cis Retinoic Acid Induces Neuronal Differentiation in Daoy (Medulloblastoma) Cells Through Epigenetic Regulation of Topoisomerase IIβ. | Appl Biochem Biotechnol | 2023 | 37000354 | PubTator, text mining | PubMed |
| Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα. | Pharmaceuticals (Basel) | 2023 | 36986441 | PubTator, text mining | PubMed |
Salt-Tolerant Plants, Halophytes, as Renewable Natural Resources for Cancer Prevention and Treatment: Roles of Phenolics and Flavonoids in Immunomodulation and Suppression of Oxidative Stress towards Cancer Management. | Int J Mol Sci | 2023 | 36982245 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=14